Siegfried Holding AG
SIX: SFZN.SW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Swiss Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Marcel Imwinkelried
- Employees
- 3,886
- Headquarters
- Zofingen, Switzerland
- IPO year
- 1995
- Market cap
- CHF 3.6B
- Website
- https://www.siegfried.ch
Loading SFZN…
Loading profile data…Frequently asked questions about SFZN
What does Siegfried Holding AG (SFZN.SW) do?
Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products. It offers contract development...
Where does SFZN.SW trade?
Siegfried Holding AG (SFZN.SW) trades on the Swiss Exchange.
What sector is SFZN.SW in?
Siegfried Holding AG (SFZN.SW) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Siegfried Holding AG?
Marcel Imwinkelried is the chief executive officer of Siegfried Holding AG (SFZN.SW).
Where is Siegfried Holding AG headquartered?
Siegfried Holding AG is headquartered in Switzerland.
Does SFZN.SW pay a dividend?
Yes — Siegfried Holding AG (SFZN.SW) paid a trailing twelve-month dividend of CHF 0.40 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SFZN.SW go public?
Siegfried Holding AG (SFZN.SW) completed its initial public offering in 1995.